UPDATED Apr 22, 2024
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
IMGN * | US$268.50 | 0% | 96.1% | US$8.4b | US$248.87 | PS29.1x | E45.2% | n/a | ||
ARDX * | US$113.80 | 0% | n/a | US$1.5b | US$237.08 | PS12.1x | E59.6% | n/a | ||
MIRM * | US$479.15 | 0% | n/a | US$1.2b | US$894.07 | PS6.6x | E63.2% | n/a | ||
HNSA N | kr160.75 | 0% | 0% | kr2.5b | kr573.38 | PS16.7x | E56.9% | n/a | ||
SGEN * | US$3,711.48 | 0% | 14.0% | US$35.9b | US$4,373.18 | PS17.5x | E65.7% | n/a | ||
ZLAB N | US$271.00 | 0% | n/a | US$1.4b | US$1,011.29 | PS5.2x | E61.8% | n/a | ||
KRTX * | US$3,226.17 | 0% | n/a | US$12.2b | US$3,297.53 | PS18680.1x | E60.0% | n/a | ||
ORY N | €48.59 | 0% | 0% | €124.4m | €248.35 | PS7.8x | E61.1% | n/a | ||
ARGX N | €6,908.59 | 0% | n/a | €21.2b | €8,493.31 | PS18.1x | E56.3% | n/a | ||
RYTM * | US$646.91 | 0% | 75.2% | US$2.3b | US$972.00 | PS29.9x | E60.9% | n/a | ||
ACAD * | US$509.00 | 0% | 60.5% | US$3.8b | US$679.54 | PS7x | E61.6% | n/a | ||
EXAS * | US$1,141.00 | 0% | n/a | US$11.1b | US$1,670.80 | PS4.4x | E61.9% | n/a | ||
BGNE N | US$2,858.16 | 0% | n/a | US$14.0b | US$5,727.85 | PS5.7x | E56.2% | n/a | ||
ICPT * | US$329.00 | 0% | 0% | US$494.0m | US$551.00 | PS1.7x | E63.9% | n/a | ||
ABCM N | US$292.38 | 0% | -2.5% | US$3.7b | US$360.48 | PS8.1x | E37.2% | 0% |